B7-1 expression decreases tumorigenicity and induces partial systemic immunity to murine neuroblastoma deficient in major histocompatibility complex and costimulatory molecules.

Immunology and Microbiology

• Histocompatibility 100%
• Systemic Immunity 100%
• Major Histocompatibility Complex 100%
• Cytotoxic T-Cell 50%
• T-Helper Cell 50%
• Cytotoxic T Cell 50%
• Immune Response 50%
• Syngenic 50%
• Immunity 50%
• Precursor 50%
• T Cell Depletion 50%
• CD8 50%
• Intercellular Adhesion Molecule 1 50%
• Retrovirus Vector 50%
• Murine 50%
• A J Mouse 50%
• Antigen Presentation 50%

Keyphrases

• Neuroblastoma 100%
• Tumorigenicity 100%
• B7-1 100%
• Systemic Immunity 100%
• Major Histocompatibility Complex Molecules 100%
• Costimulatory Molecules 100%
• Tumor 33%
• Neuro-2a 16%
• Neuro-2a Cells 16%
• Immune Response 8%
• CD8+ T Cells 8%
• Syngeneic 8%
• Costimulation 8%
• MHC Class II 8%
• CD4+ T 8%
• Antigen Presentation 8%
• Cytotoxic T Lymphocytes 8%
• In Vitro Activation 8%
• CD8+ 8%
• Intercellular Adhesion molecule-1 (ICAM-1) 8%
• Low Expression 8%
• Improved Survival 8%
• Cell Depletion 8%
• Precursor Frequency 8%
• Major Histocompatibility 8%
• Induced Mortality 8%
• Co-injection 8%
• In Vivo Priming 8%
• B7-2 8%
• Accessory Molecules 8%
• Natural Sites 8%
• Immune Attack 8%
• Anti-tumor Response 8%
• Retroviral Vector 8%